2026 LCRF | AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer

Organization
Lung Cancer Research Foundation (LCRF) and AstraZeneca
Type
Foundation
LOI or Pre-Application Due Date
07-15-2026
Application Due Date
10-05-2026
Comments
LOI submission deadline is July 15, 2026. The full proposal submission deadline is October 5, 2026.
Brief Description

The 2026 LCRF | AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer is a $500,000, three-year award that will focus on furthering the development of novel strategies towards improving the treatment of SCLC. Work supported through this mechanism will address important areas of need across the entire care continuum and have the immediate potential to increase survivorship. It is expected that correlative translational research will be proposed that will enhance the understanding of SCLC. 

Click to view SCLC grant RFP